Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

24.78USD
24 Feb 2017
Change (% chg)

$0.30 (+1.23%)
Prev Close
$24.48
Open
$24.46
Day's High
$24.88
Day's Low
$24.43
Volume
3,448,704
Avg. Vol
2,273,728
52-wk High
$25.65
52-wk Low
$16.82

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP),... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $33,742.36
Shares Outstanding(Mil.): 1,361.68
Dividend: --
Yield (%): --

Financials

Boston Scientific recalls Lotus Valve heart devices

Boston Scientific Corp said on Thursday it was recalling its Lotus range of heart devices, citing reports of problems with the locking mechanism, sending its shares down as much as 7.4 percent.

23 Feb 2017

Boston Scientific recalls all Lotus Valve heart devices

Feb 23 Boston Scientific Corp said on Thursday it was recalling its range of Lotus Valve heart devices, citing reports of problems with the locking mechanism.

23 Feb 2017

BRIEF-Boston Scientific says on Feb. 23 announced voluntary removal of all Lotus Valve devices - SEC filing

* Boston Scientific - on February 23 co announced voluntary removal of all Lotus Valve devices - SEC filing

23 Feb 2017

U.S. top court rejects Boston Scientific's patent licensing appeal

The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

21 Feb 2017

UPDATE 1-U.S. top court rejects Boston Scientific's patent licensing appeal

Feb 21 The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

21 Feb 2017

U.S. Supreme Court rejects Boston Scientific's patent licensing appeal

Feb 21 The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

21 Feb 2017

BRIEF-Boston Scientific enters into second amended, restated credit, security agreement

* Boston Scientific Corp - Boston Scientific Corporation entered into a second amended and restated credit and security agreement - SEC filing

11 Feb 2017

BRIEF-Boston Scientific sees FY 2017 GAAP earnings per share $0.86 to $0.91

* Boston scientific announces results for fourth quarter and full year ended december 31, 2016

02 Feb 2017

Bracco, Guerbet looking for partners for Bayer radiology bids: sources

FRANKFURT Italian healthcare group Bracco is working on a potential bid for the radiology supplies unit that Germany's Bayer AG is considering selling, people close to the matter said.

08 Dec 2016

BRIEF-Nevro files lawsuit for patent infringement against Boston Scientific in the U.S.

* Nevro files lawsuit for patent infringement against Boston Scientific in the U.S.

29 Nov 2016

More From Around the Web

Competitors

Earnings vs. Estimates